Skip to main content

iTeos Therapeutics, Inc.

ITOSDelisted Aug 29, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001808865

iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.

13F holders, Q4 2025

Institutional positions in iTeos Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

ITOS is no longer listed, and 13F filings after Q2 2025 list far fewer holders. See Q2 2025

Institutional holders
0
−1 vs. Q3 2025
Shares held
0
−232 (−100.0%) vs. Q3 2025
Total value
$0
−$2.35K (−100.0%) vs. Q3 2025
New holders
0
0 more added
Sold out
1
0 more reduced

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 0 institutions
Q1 2021: 81 institutionsQ2 2021: 83 institutionsQ3 2021: 77 institutionsQ4 2021: 118 institutionsQ1 2022: 159 institutionsQ2 2022: 153 institutionsQ3 2022: 143 institutionsQ4 2022: 146 institutionsQ1 2023: 153 institutionsQ2 2023: 146 institutionsQ3 2023: 144 institutionsQ4 2023: 138 institutionsQ1 2024: 136 institutionsQ2 2024: 139 institutionsQ3 2024: 151 institutionsQ4 2024: 137 institutionsQ1 2025: 132 institutionsQ2 2025: 137 institutionsQ3 2025: 1 institutionQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2025: $0
Q1 2021: $1.03BQ2 2021: $755.8MQ3 2021: $841.3MQ4 2021: $1.55BQ1 2022: $1.17BQ2 2022: $768.1MQ3 2022: $698.2MQ4 2022: $707.3MQ1 2023: $488.9MQ2 2023: $460.4MQ3 2023: $388.6MQ4 2023: $383.4MQ1 2024: $471.2MQ2 2024: $536.8MQ3 2024: $373.3MQ4 2024: $262.2MQ1 2025: $220.7MQ2 2025: $377.0MQ3 2025: $2.35KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ITOS and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20251$2.35K
Q2 2025137$377.0M
Q1 2025132$220.7M
Q4 2024137$262.2M
Q3 2024151$373.3M
Q2 2024139$536.8M
Q1 2024136$471.2M
Q4 2023138$383.4M
Q3 2023144$388.6M
Q2 2023146$460.4M
Q1 2023153$488.9M
Q4 2022146$707.3M
Q3 2022143$698.2M
Q2 2022153$768.1M
Q1 2022159$1.17B
Q4 2021118$1.55B
Q3 202177$841.3M
Q2 202183$755.8M
Q1 202181$1.03B

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q3 2025.

Institutions holding ITOS in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
IFP Advisors, Inc0$00.00%−232−100.0%Sold out